News | December 23, 2022
Strides Pharma Global receives AUD 94 mn for sale of Australia's operations
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
The new subsidiary follows the recent announcement of Tetra's partnership with Cannvalate Pty Ltd for the performance of clinical trials of Tetra's drug candidates in Australia.
They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugate (AIAC) both with global intellectual property rights
If granted, Nuvaxovid would be the first protein-based Covid-19 vaccine option for adolescents in Australia and New Zealand
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
Trescal provides precision calibration expertise in every industry, geography and instrument across the world
Moderna's vaccine has already received regulatory approval for adults and adolescents in Australia
Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia
Up to 100 million mRNA vaccine doses could be produced in Australia each year
It is a novel oral NLRP3 inflammasome inhibitor
Subscribe To Our Newsletter & Stay Updated
